Search Results Search Sort by RelevanceMost Recent Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Case and Commentary May 2020 How Should Adolescent Health Decision-Making Authority Be Shared? Kimberly Sawyer, MD and Abby R. Rosenberg, MD, MS, MA Shared decision making is complex with patients who are adolescents, whose relational autonomy is still emerging. AMA J Ethics. 2020;22(5):E372-379. doi: 10.1001/amajethics.2020.372. Medicine and Society Jun 2007 End-of-Life Care and the Goals of Medicine Bruce Jennings, MA Virtual Mentor. 2007;9(6):446-450. doi: 10.1001/virtualmentor.2007.9.6.msoc1-0706. Medicine and Society May 2007 Medical Futility: Legal and Ethical Analysis Peter A. Clark, SJ, PhD Virtual Mentor. 2007;9(5):375-383. doi: 10.1001/virtualmentor.2007.9.5.msoc1-0705. Policy Forum Mar 2007 Personalized Marketing of Health Products the 21st Century Way Joseph Turow, PhD, Robert Gellman, JD, and Judith Turow, MD Virtual Mentor. 2007;9(1):206-209. doi: 10.1001/virtualmentor.2007.9.3.pfor1-0703. Viewpoint Sep 2006 Suffering under the Auspices of Contemporary Medicine Rashmi Kudesia, ScB Virtual Mentor. 2006;8(9):617-621. doi: 10.1001/virtualmentor.2006.8.9.oped2-0609. Policy Forum Sep 2006 Should Cost Be a Consideration in Palliative Care? Maria J. Silveira, MD, MA, MPH Virtual Mentor. 2006;8(9):599-601. doi: 10.1001/virtualmentor.2006.8.9.pfor1-0609. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Case and Commentary May 2020 How Should Adolescent Health Decision-Making Authority Be Shared? Kimberly Sawyer, MD and Abby R. Rosenberg, MD, MS, MA Shared decision making is complex with patients who are adolescents, whose relational autonomy is still emerging. AMA J Ethics. 2020;22(5):E372-379. doi: 10.1001/amajethics.2020.372.
Medicine and Society Jun 2007 End-of-Life Care and the Goals of Medicine Bruce Jennings, MA Virtual Mentor. 2007;9(6):446-450. doi: 10.1001/virtualmentor.2007.9.6.msoc1-0706.
Medicine and Society May 2007 Medical Futility: Legal and Ethical Analysis Peter A. Clark, SJ, PhD Virtual Mentor. 2007;9(5):375-383. doi: 10.1001/virtualmentor.2007.9.5.msoc1-0705.
Policy Forum Mar 2007 Personalized Marketing of Health Products the 21st Century Way Joseph Turow, PhD, Robert Gellman, JD, and Judith Turow, MD Virtual Mentor. 2007;9(1):206-209. doi: 10.1001/virtualmentor.2007.9.3.pfor1-0703.
Viewpoint Sep 2006 Suffering under the Auspices of Contemporary Medicine Rashmi Kudesia, ScB Virtual Mentor. 2006;8(9):617-621. doi: 10.1001/virtualmentor.2006.8.9.oped2-0609.
Policy Forum Sep 2006 Should Cost Be a Consideration in Palliative Care? Maria J. Silveira, MD, MA, MPH Virtual Mentor. 2006;8(9):599-601. doi: 10.1001/virtualmentor.2006.8.9.pfor1-0609.